Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Pharma
Moderna Covid vaccine nears approval, FDA confirms safety
Life Sciences Times
-
December 15, 2020
0
Public Health
21% US adults not planning to get Covid vaccine: Survey
Life Sciences Times
-
December 15, 2020
0
Public Health
San Francisco administers first Covid vax to health care workers
Life Sciences Times
-
December 15, 2020
0
Pharma
Remdesivir may be highly effective against Covid: Study
Life Sciences Times
-
December 15, 2020
0
Public Health
Senecio Robotics awarded US$12 Million from the European Commission to address mosquito borne diseases
Life Sciences Times
-
December 15, 2020
0
Venture Capital
Seeqc Announces LG Technology Ventures’ Participation in Series A Funding Round
Life Sciences Times
-
December 15, 2020
0
Venture Capital
Colorado’s Life Sciences Ecosystem Raises $1.2 Billion in 2020
Life Sciences Times
-
December 15, 2020
0
Public Health
Communal Role of Cremation Specialists in Times of Pandemic
Life Sciences Times
-
December 15, 2020
0
Life Sciences
Biotech & Pharma VC Deal Activity Will Likely Exceed $20 Billion for the Second Consecutive Year: PitchBook
Life Sciences Times
-
December 15, 2020
0
Biotech
Aditum Bio Announces Formation of Third Company, Anteris Bio Anteris Bio Aimed at Treating Renal Diseases
Life Sciences Times
-
December 15, 2020
0
1
...
799
800
801
...
805
Page 800 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026